Loading...
Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus
INTRODUCTION: Cutaneous lupus erythematosus (CLE) is a chronic disease characterized by disfigurement and a relapsing course. Thalidomide has proven its efficacy in refractory cutaneous lupus disease, although it is not exempt from significant side effects and frequent relapses after withdrawal. New...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3674591/ https://ncbi.nlm.nih.gov/pubmed/23217273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar4111 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|